Intermediate-dose TBI/fludarabine conditioning for allogeneic hematopoietic cell transplantation in patients with peripheral T-cell lymphoma

Allogeneic hematopoietic cell transplantation (alloHCT) is an effective treatment for patients with relapsed/refractory peripheral T-cell lymphoma (PTCL), but the contribution of the conditioning regimen is still unclear. Here we present a retrospective single-center study using conditioning with in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Krämer, Isabelle (VerfasserIn) , König, Laila (VerfasserIn) , Luft, Thomas (VerfasserIn) , Hegenbart, Ute (VerfasserIn) , Schönland, Stefan (VerfasserIn) , Eichkorn, Tanja (VerfasserIn) , Stadtherr, Peter (VerfasserIn) , Selberg, Lorenz (VerfasserIn) , Müller-Tidow, Carsten (VerfasserIn) , Dreger, Peter (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 13 February 2025
In: Bone marrow transplantation
Year: 2025, Jahrgang: 60, Heft: 5, Pages: 581-586
ISSN:1476-5365
DOI:10.1038/s41409-025-02522-4
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1038/s41409-025-02522-4
Verlag, kostenfrei, Volltext: https://www.nature.com/articles/s41409-025-02522-4
Volltext
Verfasserangaben:Isabelle Krämer, Laila König, Thomas Luft, Ute Hegenbart, Stefan Schönland, Tanja Eichkorn, Peter Stadtherr, Lorenz Selberg, Carsten Müller-Tidow and Peter Dreger

MARC

LEADER 00000naa a2200000 c 4500
001 1931686734
003 DE-627
005 20250724084920.0
007 cr uuu---uuuuu
008 250724s2025 xx |||||o 00| ||eng c
024 7 |a 10.1038/s41409-025-02522-4  |2 doi 
035 |a (DE-627)1931686734 
035 |a (DE-599)KXP1931686734 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Krämer, Isabelle  |d 1984-  |e VerfasserIn  |0 (DE-588)1025613481  |0 (DE-627)723627738  |0 (DE-576)370555724  |4 aut 
245 1 0 |a Intermediate-dose TBI/fludarabine conditioning for allogeneic hematopoietic cell transplantation in patients with peripheral T-cell lymphoma  |c Isabelle Krämer, Laila König, Thomas Luft, Ute Hegenbart, Stefan Schönland, Tanja Eichkorn, Peter Stadtherr, Lorenz Selberg, Carsten Müller-Tidow and Peter Dreger 
264 1 |c 13 February 2025 
300 |b Illustrationen 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online veröffentlicht: 13. Februar 2025 
500 |a Gesehen am 24.07.2025 
520 |a Allogeneic hematopoietic cell transplantation (alloHCT) is an effective treatment for patients with relapsed/refractory peripheral T-cell lymphoma (PTCL), but the contribution of the conditioning regimen is still unclear. Here we present a retrospective single-center study using conditioning with intermediate-dose total body irradiation (TBI) and fludarabine for alloHCT in PTCL. Forty-seven patients underwent alloHCT for PTCL between 2010 and 2023 after conditioning with fludarabine and intermediate-dose TBI (8 Gy in 87% of the cases). In most patients alloHCT was administered as part of second-line therapy, in 22 (47%) patients after having been primary refractory, and 21 (45%) of the patients were chemoresistant at alloHCT. With a median follow-up of 5.5 years, 5-year progression-free survival (PFS), overall survival, relapse incidence, and non-relapse mortality were 61%, 65%, 24%, and 15%, respectively. The 5-year PFS of patients transplanted with stable disease and progressive disease was 57% and 26%, respectively. Of 11 relapses, only 2 (18%) occurred beyond 6 months post transplant, and no relapse was observed after onset of chronic graft-versus-host disease. AlloHCT with intermediate-dose TBI/fludarabine conditioning is associated with a favorable toxicity/efficacy profile and can provide durable survival in a substantial fraction of patients with PTCL including those with poorly controlled disease at transplant. 
650 4 |a Stem-cell therapies 
650 4 |a T-cell lymphoma 
700 1 |a König, Laila  |d 1986-  |e VerfasserIn  |0 (DE-588)1053640579  |0 (DE-627)790403315  |0 (DE-576)409584282  |4 aut 
700 1 |a Luft, Thomas  |e VerfasserIn  |0 (DE-588)1078976309  |0 (DE-627)839996969  |0 (DE-576)452120659  |4 aut 
700 1 |a Hegenbart, Ute  |e VerfasserIn  |0 (DE-588)1028373708  |0 (DE-627)73062157X  |0 (DE-576)35901903X  |4 aut 
700 1 |a Schönland, Stefan  |d 1969-  |e VerfasserIn  |0 (DE-588)122405226  |0 (DE-627)705896137  |0 (DE-576)293255792  |4 aut 
700 1 |a Eichkorn, Tanja  |e VerfasserIn  |0 (DE-588)1191801187  |0 (DE-627)167027666X  |4 aut 
700 1 |a Stadtherr, Peter  |e VerfasserIn  |0 (DE-588)1065847971  |0 (DE-627)816874557  |0 (DE-576)425538737  |4 aut 
700 1 |a Selberg, Lorenz  |d 1990-  |e VerfasserIn  |0 (DE-588)1240718985  |0 (DE-627)1769551816  |4 aut 
700 1 |a Müller-Tidow, Carsten  |d 1968-  |e VerfasserIn  |0 (DE-588)1015101798  |0 (DE-627)705330230  |0 (DE-576)351197893  |4 aut 
700 1 |a Dreger, Peter  |e VerfasserIn  |0 (DE-588)1028891881  |0 (DE-627)732699894  |0 (DE-576)376320966  |4 aut 
773 0 8 |i Enthalten in  |t Bone marrow transplantation  |d London : Springer Nature, 1997  |g 60(2025), 5 vom: Feb., Seite 581-586  |h Online-Ressource  |w (DE-627)320433366  |w (DE-600)2004030-1  |w (DE-576)091012996  |x 1476-5365  |7 nnas  |a Intermediate-dose TBI/fludarabine conditioning for allogeneic hematopoietic cell transplantation in patients with peripheral T-cell lymphoma 
773 1 8 |g volume:60  |g year:2025  |g number:5  |g month:02  |g pages:581-586  |g extent:6  |a Intermediate-dose TBI/fludarabine conditioning for allogeneic hematopoietic cell transplantation in patients with peripheral T-cell lymphoma 
856 4 0 |u https://doi.org/10.1038/s41409-025-02522-4  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.nature.com/articles/s41409-025-02522-4  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20250724 
993 |a Article 
994 |a 2025 
998 |g 1028891881  |a Dreger, Peter  |m 1028891881:Dreger, Peter  |d 910000  |d 910100  |e 910000PD1028891881  |e 910100PD1028891881  |k 0/910000/  |k 1/910000/910100/  |p 10  |y j 
998 |g 1015101798  |a Müller-Tidow, Carsten  |m 1015101798:Müller-Tidow, Carsten  |d 910000  |d 910100  |e 910000PM1015101798  |e 910100PM1015101798  |k 0/910000/  |k 1/910000/910100/  |p 9 
998 |g 1240718985  |a Selberg, Lorenz  |m 1240718985:Selberg, Lorenz  |d 50000  |e 50000PS1240718985  |k 0/50000/  |p 8 
998 |g 1065847971  |a Stadtherr, Peter  |m 1065847971:Stadtherr, Peter  |d 910000  |d 910100  |e 910000PS1065847971  |e 910100PS1065847971  |k 0/910000/  |k 1/910000/910100/  |p 7 
998 |g 1191801187  |a Eichkorn, Tanja  |m 1191801187:Eichkorn, Tanja  |d 910000  |d 911400  |e 910000PE1191801187  |e 911400PE1191801187  |k 0/910000/  |k 1/910000/911400/  |p 6 
998 |g 122405226  |a Schönland, Stefan  |m 122405226:Schönland, Stefan  |d 910000  |d 910100  |d 50000  |e 910000PS122405226  |e 910100PS122405226  |e 50000PS122405226  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 5 
998 |g 1028373708  |a Hegenbart, Ute  |m 1028373708:Hegenbart, Ute  |d 910000  |d 910100  |d 50000  |e 910000PH1028373708  |e 910100PH1028373708  |e 50000PH1028373708  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 4 
998 |g 1078976309  |a Luft, Thomas  |m 1078976309:Luft, Thomas  |d 910000  |d 910100  |d 50000  |e 910000PL1078976309  |e 910100PL1078976309  |e 50000PL1078976309  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 3 
998 |g 1053640579  |a König, Laila  |m 1053640579:König, Laila  |d 910000  |d 911400  |e 910000PK1053640579  |e 911400PK1053640579  |k 0/910000/  |k 1/910000/911400/  |p 2 
998 |g 1025613481  |a Krämer, Isabelle  |m 1025613481:Krämer, Isabelle  |d 910000  |d 910100  |e 910000PK1025613481  |e 910100PK1025613481  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1931686734  |e 4749384070 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1931686734","name":{"displayForm":["Isabelle Krämer, Laila König, Thomas Luft, Ute Hegenbart, Stefan Schönland, Tanja Eichkorn, Peter Stadtherr, Lorenz Selberg, Carsten Müller-Tidow and Peter Dreger"]},"origin":[{"dateIssuedKey":"2025","dateIssuedDisp":"13 February 2025"}],"person":[{"given":"Isabelle","display":"Krämer, Isabelle","family":"Krämer","role":"aut"},{"role":"aut","display":"König, Laila","given":"Laila","family":"König"},{"role":"aut","display":"Luft, Thomas","given":"Thomas","family":"Luft"},{"family":"Hegenbart","display":"Hegenbart, Ute","given":"Ute","role":"aut"},{"role":"aut","given":"Stefan","display":"Schönland, Stefan","family":"Schönland"},{"role":"aut","display":"Eichkorn, Tanja","given":"Tanja","family":"Eichkorn"},{"role":"aut","family":"Stadtherr","given":"Peter","display":"Stadtherr, Peter"},{"role":"aut","display":"Selberg, Lorenz","given":"Lorenz","family":"Selberg"},{"role":"aut","family":"Müller-Tidow","given":"Carsten","display":"Müller-Tidow, Carsten"},{"role":"aut","family":"Dreger","given":"Peter","display":"Dreger, Peter"}],"language":["eng"],"title":[{"title_sort":"Intermediate-dose TBI/fludarabine conditioning for allogeneic hematopoietic cell transplantation in patients with peripheral T-cell lymphoma","title":"Intermediate-dose TBI/fludarabine conditioning for allogeneic hematopoietic cell transplantation in patients with peripheral T-cell lymphoma"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"doi":["10.1038/s41409-025-02522-4"],"eki":["1931686734"]},"physDesc":[{"noteIll":"Illustrationen","extent":"6 S."}],"relHost":[{"origin":[{"publisherPlace":"London ; Basingstoke ; London","dateIssuedKey":"1997","dateIssuedDisp":"1997-","publisher":"Springer Nature ; Macmillan ; Nature Publishing Group"}],"title":[{"title":"Bone marrow transplantation","title_sort":"Bone marrow transplantation"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["320433366"],"issn":["1476-5365"],"zdb":["2004030-1"]},"part":{"pages":"581-586","year":"2025","volume":"60","text":"60(2025), 5 vom: Feb., Seite 581-586","issue":"5","extent":"6"},"note":["Gesehen am 17.01.25"],"recId":"320433366","disp":"Intermediate-dose TBI/fludarabine conditioning for allogeneic hematopoietic cell transplantation in patients with peripheral T-cell lymphomaBone marrow transplantation","language":["eng"],"pubHistory":["Nachgewiesen 19.1997 -"],"type":{"bibl":"periodical","media":"Online-Ressource"}}],"note":["Online veröffentlicht: 13. Februar 2025","Gesehen am 24.07.2025"]} 
SRT |a KRAEMERISAINTERMEDIA1320